Just more of the same from Hopper and Baker, still no update on Teva, nearly 3 years late, no news on Australian Zolpimist partner, no news on Stride, no news on Misubishi 2 deals.
IMO Hopper and Baker have delivered nothing, where is the improvement in shareholder confidence, where is the improved shareholder communication.
Really Baker needs to go, has delivered nothing but words
Ann: Investor Presentation November 2020, page-11
-
- There are more pages in this discussion • 26 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ALA (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
14.5¢ |
Change
-0.005(3.33%) |
Mkt cap ! $152.5M | |||
| Open | High | Low | Value | Volume |
| 14.8¢ | 15.0¢ | 14.3¢ | $303.9K | 2.087M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 202037 | 14.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 15.0¢ | 320045 | 4 |
View Market Depth
| Last trade - 16.10pm 13/09/2024 (20 minute delay) ? |
| ALA (ASX) Chart |